Retinal vein occlusions;Venöse retinale verschlüsse

Ophthalmologe

Volumn 100, Issue 7, 2003, Pages 561-577

  Dithmar, S ^a   Hansen, L L ^b   Holz, F G ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b NONE

Author keywords

Branch vein occlusion; Central retinal vein; Central venous occlusion; Circulatory disorders; Occlusion

Indexed keywords

DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FUNCTIONAL ANATOMY; GERMANY; HUMAN; NOMENCLATURE; PATHOGENESIS; RETINA VEIN OCCLUSION; REVIEW; SURGICAL TECHNIQUE; TREATMENT PLANNING;

DIAGNOSIS, DIFFERENTIAL; HUMANS; ISCHEMIA; PATIENT CARE TEAM; PROGNOSIS; RETINAL DISEASES; RETINAL HEMORRHAGE; RETINAL NEOVASCULARIZATION; RETINAL VEIN OCCLUSION; RISK FACTORS;

EID: 0041808863     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-003-0820-4     Document Type: Review

References (96)

1. Antcliff RJ, Spalton DJ, Stanford MR et al. (2001) Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 108:765-772
2. Appiah AP, Trempe CL (1989) Risk factors associated with branch vs. central retinal vein occlusion. Ann Ophthalmol 21:153-157
3. Arend O, Remky A, Stolbach U et al. (1996) Digitale Fluoreszein-Angiographie zur Kontrolle des klinischen Verlaufes unter Therapie bei Patienten mit Zentralvenenverschluß und zystoidem Makulaödem. Klin Monatsbl Augenheilkd 209:163-170
4. Amarsson A, Stefansson E (2000) Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 41:877-879
5. Bertram B, Haase G, Remky A, Reim M (1994) Anti-Cardiolipin-Antikörper bei Gefäßverschlüssen aro Auge. Ophthalmologe 91:768-771
6. Bertram B, Remky A, Arend O et al. (1995) Protein C, protein S, and antithrombin III in acute ocular occlusive diseases. Germ J Ophthalmol 4:332-335
7. Branch Vein Occlusion Study Group (1986) Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. Arch Ophthalmol 104:34-41
8. Brown G (1985) Central retinal vein occlusion: diagnosis and management. Ophthalmol Ann 1:65-98
9. Brunner R, Heinen A, Konen W (1985) Indikation, Kontraindikation und therapeutisches Risiko der Hämodilution unter Berücksichtigung von Hypertonie, Herzinsuffizienz und koronarer Herzkrankheit. Fortschr Ophthalmol 82:622-628
10. Bynoe LA (2002) Radial optic neurotomy for central retinal vein occlusion. Retina 22:379-380; discussion 380-381
11. Central Vein Occlusion Study Group (1997) Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115:486-491
12. Central Vein Occlusion Study Group (1995) A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. Ophthalmology 102:1434-1444
13. Central Vein Occlusion Study Group (1993) Baseline and early natural history report. Arch Ophthalmol 111:1087-1095
14. Central Vein Occlusion Study Group (1995) Evaluation or grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology 102:1425-1433
15. Chern S, Magargal LE, Annesley WH (1991) Central retinal vein occlusion associated with drusen of the optic disc. Ann Ophthalmol 23:66-69
16. Christoffersen NL, Larsen M (1999) Pathophysiology and hemodynamics of branch vein occlusion. Ophthalmology 106:2054-2062
17. Ciardella AP, Yannuzzi LA, Freund KB et al. (1998) Factor V Leiden, activated protein C resistance, and retinal vein occlusion. Retina 18:308-315
18. Cobo-Soriano R, Sanchez-Ramon S, Aparicio MJ et al. (1999) Antiphospholipid antibodies and retinal thrombosis in patients without risk factor: a prospective case-control study. Am J Ophthalmol 128:725-732
19. Dahlback B (1995) Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism. J Intern Med 237:221-227
20. David R, Zangwill L, Badarna M, Yassur Y (1988) Epidemiology of retinal vein occlusion and its association with glaucoma and increased intraocular pressure. Ophthalmologica 197:69-74
21. Elman MJ (1996) Thrombolytic therapy for central retinal vein occlusion: results of a pilot study. Trans Am Ophthalmol Soc 126:471-504
22. Elman MJ, Raden RZ, Carrigan A (2001) Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 99:219-221
23. Faude S, Faude F, Siegemund A, Wiedemann P (1999) APC-Resistenz bei Patienten mit Zentralvenenverschluß. Vergleich mit Patienten mit tiefer Becken-Beinvenenthrombose und gesunder Kontrollgruppe. Opthalmologe 96:594-599
24. Feist RM, Ticho BH, Shapiro MJ, Farber M (1992) Branch retinal vein occlusion and quadratic variation in arteriovenous crossings. Am J Ophthalmol 113:664-668
25. Finkelstein D (1992) Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol 110:1427-1434
26. Fong A, Schatz H, Mc Donald HR et al. (1992) Central retinal vein occlusion in young adults. Retina 12:3-11
27. Fong A, Schatz H (1993) Central retinal vein occlusion in young adults. Surv Opthalmol 37:393-417
28. Frangieh GT, Green WR, Barraquer-Sommers E et al. (1982) Histopathologic study of nine branch retinal vein occlusion. Arch Ophthalmol 100:1132-1140
29. Galvin R, Sanders MD (1980) Peripheral retinal haemorrhages with papilloedema. Br J Ophthalmol 64:262-266
30. Glacet-Bernard A, Coscas G, Chabanel A et al. (1996) Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 103:551-560
31. Glacet-Bernard A, Bayani N, Chretien P et al. (1994) Antiphospholipid antibodies in retinal vascular occlusions. Arch Ophthalmol 112:790-795
32. Glacet-Bernard A, Kuhn D, Vine AK et al. (2000) Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol 84:609-613
33. Glacet-Bernard A, Zourdani A, Milhoub M et al. (2001) Effect of isovolemic hemodilution in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 239:909-914
34. Greenberg PB, Martidis A, Rogers AH et al. (2002) Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 86:247-248
35. Greiner K, Hafner G, Dick B et al. (1999) Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol 128:69-74
36. Hansen LL, Danisevskis P, Arntz HR et al. (1985) A randomised prospective study of treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation. Br J Ophthalmol 69:108-116
37. Hansen LL, Wiek J, Wiederholt M (1989) A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution, Br J Ophthalmol 73:89S-899
38. Hansen LL (1994) Behandlungsmöglichkeiten bei retinalen Zentralvenenverschlüssen. Ophthalmologe 91:131-145
39. Hattenbach LO (1998) Systemische Lysetherapie bei retinalen Gefäßverschlüssen. Ophthalmologe 9S:568-575
40. Hayreh SS (1996) The CVOS Group M and N reports [letter]. Ophthalmology 103:350-352
41. Hayreh SS (2002) Radial optic neurotomy for central retinal vein occlusion. Retina 22:374-377; discussion 377-379
42. Hayreh SS, Klugman MR, Beri M et al. (1990) Differentiation of ischemic from nonischemic central retinal vein occlusion during early acute phase. Graefes Arch Clin Exp Ophthalmol 228:201-217
43. Hayreh SS, Klugman MR, Podhajsky P et al. (1990) Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study. Graefes Arch Clin Exp Ophthalmol 228:281-296
44. Hayreh SS, Zimmermann MB, Podhalsky P (1994) Incidence of various types of retinal vein occlusion and their recurrence and democraphic characteristics. Am J Ophthalmol 117:429-441
45. Hitchings RA, Spaeth GL (1976) Chronic RVO in glaucoma. Br J Ophthalmol 60:694-699
46. Jefferies P, Clemett R, Day T (1993) An anatomical study of retinal arteriovenous crossings their role in the pathogenesis of retinal branch vein occlusion. Aust N Z J Ophthalmol 21:213-217
47. Johnson TM, El-Defrawy S, Hodge WG et al. (2001) Prevalence of factor V Leiden and activated protein C resistance in central retinal vein occlusion. Retina 21:161-166
48. Jonas JB, Kreissig I, Degenring RF (2002) Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240:782-783
49. Jonas JB, Sofker A (2001) Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132:425-427
50. Kirkham TH, Wrigley PF, Holt JM (1971) Central retinal vein occlusion complicating iron deficiency anaemia. Br J Ophthalmol 55:777-780
51. Klein ML, Finkelstein D (1989) Macular grid photocoagulation for macular edema in central retinal vein occlusion. Arch Ophthalmol 107:1297-1302
52. Kohner EM, Pettit JH, Hamilton AM et al. (1976) Streptokinase in central retinal vein occlusion: a controlled clinical trial. Br Med J 1:550-553
53. Lahey JM, Fong DS, Kearney J (1999) Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers 30:427-434
54. Lahey JM, Tunc M, Kearney J et al. (2002) Laboratory evaluation of hypercoagulable states in patient with central retinal vein occlusion who are less than 56 years of age. Ophthalmology 109:126-131
55. Lang GE, Freißler K (1992) Klinische und fluoreszein-angiographische Befunde bei Patienten mit retinalen Venenastverschlüssen. Klin Monatsbl Augenheilkd 201:234-239
56. Lang GE (1993) Ergebnisse der Laserkoagulation retinaler Zentralvenenverschlüsse. Klin Monatsbl Augenheilkd 203:247-251
57. Larsson J, Olafsdottir E, Bauer B (1996) Activated protein C resistance in young adults with central vein occlusion. Br J Ophthalmol 80:200-202
58. Le Rouic JF, Bejjani RA, Rumen F et al. (2001) Adventitial sheathotomy for decompression of recent onset branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 239:747-751
59. Lerche RC., Wilhelm C, Eifrig B, Richard G (2001) Thrombophiliefaktoren als Auslöser retinaler Gefäßverschlüsse. Ophthalmologe 98:529-534
60. Luntz MH, Schenker HI (1980) Retinal vascular accidents in glaucoma and ocular hypertension. Surv Ophthalmol 25:163-167
61. Machemer R, Sugita G, Tano Y (1979) Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 77:171-180
62. Magargal LE, Gonder JR, Maher V (1985) CRVO in the young adult. Trans PA Acad Ophthalmol Otolaryngol 37:143-153
63. Matrai A, Ernst E (1985) Pentoxifylline improves white cell rheology in claudicants. Clin Hemorheol 5:483-491
64. McAllister IL, Constable IJ (1995) Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion. Arch Ophthalmol 113:456-462
65. McAllister IL, Douglas JP, Constable IJ, Yu DY (1998) Laser-induced chorioretinal venous anastomosis for nonischemic central retinal vein occlusion: evaluation of the complications and their risk factors. Am J Ophthalmol 126:219-229
66. McLeod D, Ring CP (1976) Cilloretinal infarction after retinal vein occlusion. Br J Ophthalmol 60:419-427
67. Mester U, Dillinger P (2001) Behandlung retinaler Venenastverschlüsse. Ophthalmologe 98:1104-1109
68. Opremcak EM, Bruce RA (1999) Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy. A prospective review of 15 cases. Retina 19:1-5
69. Opremcak EM, Bruce RA, Lomeo MD et al. (2001) Radial optic neurotomy for central retinal vein occlusion. Retina 21:408-415
70. Osterloh MD, Charles S (1988) Surgical decompression of branch retinal vein occlusions. Arch Ophthalmol 106:1469-1471
71. Parodi MB, Saviano S, Ravalico G (1999) Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 237:1024-1027
72. Rath EZ, Frank RN, Shin DH, Kim C (1992) Risk factors for retinal vein occlusions. A case-control study. Ophthalmology 99:509-514
73. Reim M, Bertram B, Wolf S (1988) Behandlungsversuche der Zentra(venenthrombose der Netzhaut mit rt-PA. Klin Wochenschr 66:143-149
74. Rodriguez N, Eliott D (2001) Occlusion in Eisenmenger Syndrom. Am J Ophthalmol 132:268-269
75. Saika S, Tanaka T, Miyamoto T, Ohnishi Y (2001) Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: retinal tomography and visual outcome. Graefes Arch Clin Exp Ophthalmol 239:729-732
76. Schatz H, Fong AC, McDonald HR et al. (1991) Cilio-retinal artery occlusion in young adults with central retinal vein occlusion. Ophthalmology 98:594-601
77. Schindler RH, Chandler DB, Thresher R, Machemer R (1982) The clearance of intravitreal triamcinolone acetonide. Am J Ophthalmol 93:415-417
78. Schmack I, Dithmar S (2002) Prophylaktische Pankoagulation von ischämischen Zentralvenenverschlüssen? Praktikabilität der Ergebnisse der Central Vein Occlusion Study Group (CVOSG). Ophthalmologe 99 [Suppl 1]:5132
79. Schmidt D, Schumacher M (1991) Zentralvenenverschluß als Folge von spontanen arteriovenösen Fisteln der A. carotis zum Sinus cavernosus. Fortschr Ophthalmol 88:683-686
80. Seitz R (1962) Die Netzhautgefäße. Vergleichende ophthalmoskopische und histologische Studien an gesunden und kranken Augen. Beihefte Klin Monatsbl Augenheilkd 40
81. Shah GK, Sharma S, Fineman MS et al. (2000) Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 129:104-106
82. Shaikh S, Blumenkranz MS (2001) Transient improvement in visual acuity and macular edema in central retinal vein occlusion accompanied by inflammatory features after pulse steroid and anti-inflammatory therapy. Retina 21:176-178
83. Stefansson E (2001) The therapeutic effect of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scan 79:435-440
84. Steinkamp GWK, Hattenbach LO, Scharrer I, Ohrloff C (1994) Front-loading-rt-PA-Lysetherapie bei Zentraloder Venenastverschlüssen der Netzhaut. Ophthalmologe 91:280-282
85. Tang WH, Han DP (2000) A study of surgical approaches to retinal vascular occlusions. Arch Ophthalmol 118:138-143
86. Ten Doesschate MJL, Manschott WA (1985) Optic disc drusen and central vein occlusion. Documenta Ophthalmol 59:27-31
87. The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macula edema in branch vein occlusion. Am J Ophthalmol 98:271-282
88. Triebe G, Münnich U, Liebold F (1992) Therapievergleich zwischen Hämodilution und Pentoxifyllin bei arterieller Verschlußkrankheit. Dtsch Med Wochenschr 117:523-530
89. Weinberg D, Dodwell DG, Fern SA (1990) Anatomy of arteriovenous crossing in branch retinal vein occlusion. Am J Ophthalmol 109:298
90. Weinberg DV, Egan KM, Seddon JM (1993) Asymmetric distribution of arteriovenous crossings in the normal retina. Ophthalmology 100:31-36
91. Weiss JN (1998)Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol 126:142-144
92. Weiss JN, Bynoe LA (2001) Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 108:2249-2257
93. Wiechens B, Schroder JO, Potzsch B, Rochels R (1997) Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy. Am J Ophthalmol 123:848-850
94. Williams GA, Sarrafizadeh R (2000) Antiphospholipid antibodies and retinal thrombosis in patients without risk factors: a prospective case-control study [Letter]. Am J Ophthalmol 130:538
95. Wolf S, Arend O, Bertram B et al. (1994) Hemodilution therapy in central retinal vein occlusion. One year results of a prospective randomized study. Graefes Arch Clin Exp Ophthalmol 232:33-39
96. Wolf S, Arend O, Bertram B et al. (1991) Hämodilution bei Patienten mit Zentralvenenthrombose der Retina. Fortschr Ophthalmol 88:35-43